• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子受体家族成员CD27通过Traf-2向Jun氨基末端激酶发出信号。

The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2.

作者信息

Gravestein L A, Amsen D, Boes M, Calvo C R, Kruisbeek A M, Borst J

机构信息

Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam.

出版信息

Eur J Immunol. 1998 Jul;28(7):2208-16. doi: 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L.

DOI:10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L
PMID:9692890
Abstract

CD27 is a lymphocyte-specific member of the TNF receptor (TNFR) family. It is a costimulatory molecule for peripheral T cells, as defined by its ability to enhance the TCR-induced proliferative response. We show here that CD27 augments TCR-induced Jun N-terminal kinase (JNK) activity in primary murine lymph node T cells. To investigate how CD27 couples to JNK, we performed a yeast two hybrid screen with the CD27 cytoplasmic tail. This revealed that CD27 directly associates with Traf-2. Transfection experiments using dominant negative Traf-2 indicated that CD27 communicates with JNK via Traf-2. These findings group CD27 together with other members of the TNFR family, TNFR-1, -2, CD30 and CD40, which have all been shown to couple to Traf proteins. Since Traf proteins have been reported to initiate an anti-apoptotic signaling pathway, our data suggest that CD27 not only regulates proliferation, but also survival of T lymphocytes.

摘要

CD27是肿瘤坏死因子受体(TNFR)家族中的淋巴细胞特异性成员。它是外周T细胞的共刺激分子,其增强TCR诱导的增殖反应的能力可对此进行定义。我们在此表明,CD27可增强原代小鼠淋巴结T细胞中TCR诱导的Jun N末端激酶(JNK)活性。为了研究CD27如何与JNK偶联,我们用CD27细胞质尾进行了酵母双杂交筛选。这表明CD27直接与Traf-2相关联。使用显性负性Traf-2的转染实验表明,CD27通过Traf-2与JNK进行通信。这些发现将CD27与TNFR家族的其他成员TNFR-1、-2、CD30和CD40归为一组,所有这些成员均已被证明可与Traf蛋白偶联。由于据报道Traf蛋白可启动抗凋亡信号通路,我们的数据表明CD27不仅调节T淋巴细胞的增殖,还调节其存活。

相似文献

1
The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2.肿瘤坏死因子受体家族成员CD27通过Traf-2向Jun氨基末端激酶发出信号。
Eur J Immunol. 1998 Jul;28(7):2208-16. doi: 10.1002/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L.
2
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.CD27是肿瘤坏死因子受体超家族的一员,通过TRAF2、TRAF5和NF-κB诱导激酶激活NF-κB和应激激活蛋白激酶/c-Jun N端激酶。
J Biol Chem. 1998 May 22;273(21):13353-8. doi: 10.1074/jbc.273.21.13353.
3
Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.应激激酶途径在通过T细胞共刺激受体4-1BB进行信号传导中的作用。
J Immunol. 1999 Sep 15;163(6):2990-8.
4
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.Traf5基因的靶向破坏导致CD40和CD27介导的淋巴细胞活化缺陷。
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9803-8. doi: 10.1073/pnas.96.17.9803.
5
CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.CD27是肿瘤坏死因子受体家族的一员,可诱导细胞凋亡并与促凋亡蛋白Siva结合。
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6346-51. doi: 10.1073/pnas.94.12.6346.
6
TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways.肿瘤坏死因子(TNF)通过平行的肿瘤坏死因子受体相关因子(TRAF)-核因子κB(NF-κB)和TRAF-小G蛋白RAC/细胞分裂周期蛋白42(CDC42)-应激活化蛋白激酶(JNK)-c-Jun/活化转录因子2(ATF2)途径启动人内皮细胞中E-选择素的转录。
J Immunol. 1997 Oct 1;159(7):3508-18.
7
Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.肿瘤坏死因子α诱导的c-jun氨基末端激酶激活由TRAF2介导。
EMBO J. 1997 Mar 3;16(5):1080-92. doi: 10.1093/emboj/16.5.1080.
8
Novel mAbs reveal potent co-stimulatory activity of murine CD27.
Int Immunol. 1995 Apr;7(4):551-7. doi: 10.1093/intimm/7.4.551.
9
Translocation of TRAF proteins regulates apoptotic threshold of cells.TRAF蛋白的易位调节细胞的凋亡阈值。
Biochem Biophys Res Commun. 2000 Jun 16;272(3):936-45. doi: 10.1006/bbrc.2000.2873.
10
TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.肿瘤坏死因子受体相关因子3信号传导介导人B细胞上CD40连接后p38和Jun N端激酶的激活、细胞因子分泌及免疫球蛋白产生。
J Immunol. 1998 Aug 1;161(3):1183-93.

引用本文的文献

1
Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.阿奇霉素靶向 CD27 通路调节 CD27hiT 淋巴细胞扩增和 1 型效应表型。
Front Immunol. 2024 Aug 15;15:1447625. doi: 10.3389/fimmu.2024.1447625. eCollection 2024.
2
Cytomegalovirus infection reduced CD70 expression, signaling and expansion of viral specific memory CD8 T cells in healthy human adults.巨细胞病毒感染降低了健康成年人中病毒特异性记忆CD8 T细胞的CD70表达、信号传导及扩增。
Immun Ageing. 2022 Nov 11;19(1):54. doi: 10.1186/s12979-022-00307-7.
3
TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.
肿瘤坏死因子受体相关因子2(TRAF2)在癌症中的信号传导
Cancers (Basel). 2022 Aug 22;14(16):4055. doi: 10.3390/cancers14164055.
4
Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.精神分裂症、双相情感障碍和重度抑郁症患者的细胞因子 B 细胞激活因子 (BAFF) 和增殖诱导配体 (APRIL) 的血浆水平:一项横断面、多中心研究。
Schizophr Bull. 2022 Jan 21;48(1):37-46. doi: 10.1093/schbul/sbab106.
5
Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer.肿瘤内在免疫相关蛋白可能是某些类型癌症中的新型肿瘤抑制因子。
Sci Rep. 2019 Jul 29;9(1):10918. doi: 10.1038/s41598-019-47382-3.
6
Genetic Aberrations Associated with Photodynamic Therapy in Colorectal Cancer Cells.与结直肠癌细胞光动力疗法相关的遗传异常。
Int J Mol Sci. 2019 Jul 2;20(13):3254. doi: 10.3390/ijms20133254.
7
Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.癌症免疫治疗中的共刺激和共抑制途径。
Adv Cancer Res. 2019;143:145-194. doi: 10.1016/bs.acr.2019.03.003. Epub 2019 Apr 17.
8
Stimulating T Cells Against Cancer With Agonist Immunostimulatory Monoclonal Antibodies.用激动剂免疫刺激单克隆抗体刺激针对癌症的 T 细胞。
Int Rev Cell Mol Biol. 2019;342:1-25. doi: 10.1016/bs.ircmb.2018.07.003. Epub 2018 Aug 20.
9
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.RIVA - 利妥昔单抗和瓦利单抗治疗复发或难治性B细胞恶性肿瘤的IIa期研究:一项随机对照试验的研究方案
Trials. 2018 Nov 9;19(1):619. doi: 10.1186/s13063-018-2996-6.
10
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.CD27激动剂通过髓系细胞募集增强抗体肿瘤靶向作用。
Cancer Cell. 2017 Dec 11;32(6):777-791.e6. doi: 10.1016/j.ccell.2017.11.001. Epub 2017 Nov 30.